IRTC 82.45 (+0.16%)
US4500561067• Medical Devices & Instruments• Medical Instruments & Supplies
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. IRTC

IRhythm Technologies (IRTC) Competitor Comparison

We are evaluating the key criteria listed to compare IRhythm Technologies (IRTC) against its competitors in the Medical Instruments & Supplies industry.

Market Capitalization

19 / 44

Gross Profits

21 / 40

Total Revenue

22 / 43

EBITDA

42 / 44

Free Cashflow

25 / 44

Quick Ratio

21 / 44

Earnings per Share

42 / 44

Dividend yield

0 / 13

Total Cash

22 / 44

Performance 3 years

19 / 44

Performance 5 years

17 / 44

Performance 10 years

16 / 44

Linearity 3 years

11 / 44

Linearity 5 years

1 / 44

Linearity 10 years

19 / 44

Total Rank

14 / 44

Dividend Rank

22 / 44

Valuation Rank

18 / 44

Piotroski Rank

28 / 44

Muliplier Rank

43 / 44

Total Rank - IRTC ranking 14 / 44

These are the competitors of IRhythm Technologies in the industry Medical Instruments & Supplies ranked by total rank
1. Hologic HOLX
4
2. ResMed RMD
3
3. Ansell PD1.F
3
4. Bausch & Lomb BLCO
3
5. West Pharmaceutical Services WST
3
6. Baxter BAX
3
7. Envista Holdings NVST
3
8. Teleflex TFX
3
9. Becton, Dickinson BDX
3
10. Merit Medical Systems MMSI
3
11. Masimo MASI
3
12. ICU Medical ICUI
2
13. Intuitive Surgical ISRG
2
14. iRhythm Technologies IRTC
2
15. KORU Medical Systems KRMD
2
16. LeMaitre Vascular LMAT
2
17. Nephros NEPH
2
18. NeuroMetrix NURO
2
19. NexGel NXGL
2
20. NovoCure NVCR
2
21. OraSure Technologies OSUR
2
22. Predictive Oncology POAI
2
23. Pro-Dex PDEX
2
24. Pulse Biosciences PLSE
2
25. Repligen RGEN
2
26. Steris STE
2
27. Alcon ALC
2
28. AngioDynamics ANGO
2
29. AtriCure ATRC
2
30. Atrion ATRI
2
31. BioLife Solutions BLFS
2
32. Dentsply Sirona XRAY
2
33. electroCore ECOR
2
34. Glaukos GKOS
2
35. Haemonetics HAE
2
36. Harvard Bioscience HBIO
2
37. Staar Surgical STAA
2
38. Cooper Companies COO
2
39. Utah Medical Products UTMD
2
40. Warby Parker WRBY
2
41. Microbot Medical MBOT
1
42. Ekso Bionics Holdings EKSO
1
43. Akoya Biosciences AKYA
1
44. Femasys FEMY
1
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.